Delivery Order SPE2DR25D2104-SPE2DR26F3NWE
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,642.05 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packages) under a firm fixed price contract. The award was made on September 16, 2025, with an ultimate completion date of September 17, 2025, and represents a non-competitive delivery against an existing contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform this delivery order from its...
- The Defense Logistics Agency awarded a delivery order valued at $1,344.93 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count package) on August 12, 2025, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order represents a non-competitive set-aside award and is performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor providing critical medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $11,746.44 to AmerisourceBergen Drug Corp for the supply of Kerendia 20 mg tablets (90-count units) under a firm fixed-price contract. The delivery order was competitively awarded without set-aside designation on July 15, 2025, with an ultimate completion date of July 16, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a discrete...
- The Defense Logistics Agency awarded a $7,668.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units) on July 31, 2025, with an ultimate completion date of August 1, 2025. This non-competitive delivery order represents a routine pharmaceutical procurement executed under AmerisourceBergen's existing contract vehicle with DLA. The product will be delivered to Conshohocken, Pennsylvania, the company's corporate headquarters location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on October 27, 2025, with a ceiling value of $1,466.44 and an ultimate completion date of October 28, 2025. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded transaction under AmerisourceBergen's existing pharmaceutical supply contract with DLA. The place of performance is located in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order valued at $12,842.64 to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, and performance will be completed by August 14, 2025, at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical...
- The Defense Logistics Agency awarded a delivery order valued at $2,910.33 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (30-count packaging) with an ultimate completion date of November 12, 2025. This non-set-aside, competitively awarded contract employs firm fixed pricing and represents a child delivery order under a larger indefinite delivery vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order valued at $3,320.29 to AmerisourceBergen Drug Corp on July 23, 2025, for the supply of Kerendia 10 mg tablets (30-count packaging). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 24, 2025. The pharmaceutical will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a competitive delivery order valued at $1,603.18 to AmerisourceBergen Drug Corp for Kerendia 20 mg tablets (90-count units), with an ultimate completion date of November 14, 2025. This non-set-aside contract represents a firm fixed price delivery order supporting federal pharmaceutical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a $5,928.25 firm fixed price delivery order to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count units) on October 31, 2025, with a completion date of November 3, 2025. This competitively awarded, non-set-aside contract represents a small-value pharmaceutical procurement for military healthcare supply needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3NWEDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,899.19 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on November 12, 2025, with an ultimate completion date of November 13, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office in Conshohocken, Pennsylvania. The award represents a competitive procurement of pharmaceutical products supporting federal medical supply needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical federal healthcare vendor, AmerisourceBergen Drug Corp serves multiple government healthcare systems including the Defense Health Agency and U.S. Coast Guard through this comprehensive global pharmaceutical support vehicle. The company's federal contract portfolio demonstrates extensive experience delivering a wide range of medications and medical supplies across multiple therapeutic domains to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.9k | 11/12/25 |